Larimar Therapeutics, Inc.: Form 8-K, filed Feb 7, 2023
Filed with the SEC on Feb 7, 2023 and accepted by EDGAR at Feb 7, 2023, 16:20 ET.
Items reported
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-23-026958. Last ingested by Listed: Nov 13, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.